For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

singup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 7

Based on the information you provided, we found the following studies.

  • Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and Graft-versus-host Disease in Allogeneic Hematopoietic Cell Transplantation for High-risk Hematologic Malignancies Investigational drug carfilzomib will be added to a standard chemotherapy conditioning regimen for donor blood stem cell transplant to test if this new conditioning regimen can lead to safe and more effective stem cell transplant treatment approach for patients with quickly worsening blood cancers. This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) AML ( Acute myeloid leukemia ) Amyloidosis CLL ( Chronic lymphocytic leukemia) Leukemia Lymphoma MDS ( Myelodysplastic syndrome ) Multiple myeloma Myelofibrosis Non-Hodgkin's lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • Less than 66 years old
    • More than 18 years old
  • Phase 1b/2 Open Label, Dose Escalation Study to Determine Safety & Efficacy of ACY-1215 in Combination with Pomalidomide & Low-dose Dexamethasone in Patients w/ Relapsed & Refractory Multiple Myeloma This part of the study will study will examine how well the drug regimen combination of ACY-1215, when given with pomalidomide and low dose dexamethasone, works, and continue to test the safety of ACY-1215 given at the best dose and schedule, as determined in the first part of this study. This study is researching all of the following topics: Multiple myeloma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 1/2 Dose Escalation Safety, Pharmacokinetic and Efficacy Study of Multiple IV Administrations of SAR650984 Against CD38 In Patients with Selected CD38+ Hematological Malignancies The main purpose of this study is to evaluate the possible risks and the effectiveness of investigational drug SAR650984 in patients with multiple myeloma. This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) AML ( Acute myeloid leukemia ) CLL ( Chronic lymphocytic leukemia) Multiple myeloma Non-Hodgkin's lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase 3 Double Blind, Randomized Oral MLN9708/Rev/Dex vs. Placebo/Rev/Dex in Adults with Newly Diagnosed Multiple Myeloma (Protocol C16014) The study purpose is to determine whether adding investigational drug MLN9708 to the combination of lenalidomide and dexamethasone improves survival in patients with newly diagnosed multiple myeloma. This study is researching all of the following topics: Multiple myeloma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • RVD +/- transplant in the Initial Management of Myeloma in Patients up to 65 Years of Age We are looking to explore the drug combination of lenalidomide, bortezomib, and dexamethasone alone or when combined with autologous stem cell transplantation to see what side effects if may have and how well it works for treatment of newly diagnosed multiple myeloma. This study is researching all of the following topics: Multiple myeloma This study is looking for: male female both men and women Volunteers with specific conditions
    • 18 years to 65 years
  • Multicenter, Open-label Phase Ib/2 Study of the Combination Treatment with Pomalidomide, Dexamethasone and Carfilzomib in Subjects with Relapsed and Relapsed/Refractory Multiple Myeloma This study is being done to learn more about a combination of 3 drugs called pomalidomide, dexamethasone, and carfilzomib given to persons with multiple myeloma which has gotten worse and is not responding to the standard drugs for multiple myeloma, such as velcade, thalidomide, and corticosteroids. This study is researching all of the following topics: Multiple myeloma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 1b Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Relapsed or Refractory Multiple Myeloma Subjects who are Receiving Bortezomib and Dexamethasone as their Standard Therapy This is an open-label study designed to determine the safety, pharmacokinetics, maximum tolerated dose, and the recommended Phase 2 dose of the experimental drug ABT-199 when administered in relapsed This study is researching all of the following topics: Multiple myeloma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old